FORTHCOMING | Horizon Europe Health Call 2027: Development of Innovative Antimicrobials Against Drug-Resistant Pathogens

The European Commission has announced a forthcoming Horizon Europe Cluster 1: Health funding opportunity aimed at accelerating the development of innovative antimicrobial therapies to combat antimicrobial-resistant (AMR) bacterial and fungal pathogens.

Antimicrobial resistance remains one of the most

Development of Monoclonal Antibodies to Prevent and Treat Infections from Filo-, Nairo-, Phenui-, Picorna- and Toga Viruses

Programme: Horizon Europe (HORIZON) – Cluster 1: Health
Topic Code: HORIZON-HLTH-2027-01-DISEASE-07
Type of Action: Research and Innovation Action (RIA)
Funding Type: Horizon Europe Grant Funding
Opening Date: 10 February 2027
Closing Date: 13 April 2027 (17:00 Brussels Time)

The European Commission